相关实验视频
Updated: Jul 18, 2025

13:28
Methodology for Sputum Induction and Laboratory Processing
Published on: December 17, 2017
27.7K
与喘单独相比,喘-COPD重叠的患者中疹性中耳炎的发病率和严重程度更高
Emiri Sato1, Yukako Seo2, Etsuko Tagaya3
1Department of Otorhinolaryngology, Tokyo Women's Medical University, Tokyo, Japan, sato.emiri@twmu.ac.jp.
International archives of allergy and immunology
|August 24, 2023
概括
喘-COPD重叠 (ACO) 在慢性鼻炎患者中增加了异性中耳炎 (EOM) 的患病率和严重程度. 戒烟和早期ACO治疗可能会减少这些患者的EMO.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 炎症研究 炎症研究
背景情况:
- 生性中耳炎 (EOM) 经常与成人发作的喘共存,共享2型炎症途径.
- 喘-COPD重叠 (ACO) 是一种具有较高死亡率的严重疾病,其特征是气道壁加厚 (AWT).
- "一个呼吸道,一个疾病"的概念表明基于喘或ACO并发症的不同EOM病理生理学.
研究的目的:
- 调查EOM病理生理学在慢性鼻炎患者中仅仅是喘患者与伴随性ACO患者的病理生理学不同之处的假设.
- 为了比较喘和ACO组之间的临床特征,EOM患病率,严重程度和中耳溢出 (MEE) 细胞数量.
主要方法:
- 77名患有喘的慢性鼻炎患者被分为仅喘 (46) 和ACO (31) 组.
- 对比包括临床数据,EMO患病率/严重程度,吸烟史 (布林克曼指数),AWT (CT扫描) 和MEE乙烯基蛋白/中性蛋白计数.
主要成果:
- 在ACO组有更多的男性,年龄较大,肺功能较低,吸烟史较高,AWT更高.
- 在ACO组中,EMO患病率和严重程度显著更高,与ACO严重程度相关.
- 与喘组相比,MEE在ACO组中显示出较低的乙氨基粒 (25.3%与54.7%) 和较高的中性粒 (75.7%与41.9%).
结论:
- 喘患者的ACO并发症与EOM患病率和严重程度的增加有关,中耳中性粒细胞透率较高.
- 戒烟和早期ACO干预可以减少AWT的进展,并减轻EOM的患病率和严重程度.
相关概念视频
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
COPD: Management Using Bronchodilators and Corticosteroids
244
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
244
Asthma: Pathogenesis and Management
443
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
443
Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K

